GT
51
22
ETR
68
-3
OXY
34
2
CL
50
-8
DE
63
5
ITW
52
2
XRX
34
2
HBAN
65
5
SLG
31
3
KMX
70
5
WU
20
8
CSX
43
2
IR
40
-7
HPQ
59
3
NOV
53
-2
TSN
44
-2
WYNN
42
14
VNO
57
5
FIS
53
2
CB
31
-2
GT
51
22
ETR
68
-3
OXY
34
2
CL
50
-8
DE
63
5
ITW
52
2
XRX
34
2
HBAN
65
5
SLG
31
3
KMX
70
5
WU
20
8
CSX
43
2
IR
40
-7
HPQ
59
3
NOV
53
-2
TSN
44
-2
WYNN
42
14
VNO
57
5
FIS
53
2
CB
31
-2
Financhill
Back

Franklin Street Properties Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
33

FSP
Franklin Street Properties

Last Price:
$2.00
Seasonality Move:
-6.45%
Sell
41

SRPT
Sarepta Therapeutics

Last Price:
$107.93
Seasonality Move:
1.75%
Sell
33
Franklin Street Properties (FSP) is a Sell

Is Franklin Street Properties a Buy, Sell or Hold?

  • The current Franklin Street Properties [FSP] share price is $2.00. The Score for FSP is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • FSP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $107.95. The Score for SRPT is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FSP Stock Price Chart

What is Franklin Street Properties's stock price today?

  • The Franklin Street Properties share price today is $2.00
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FSP is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $107.95
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

FSP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.03 Buy
Relative Strength Index (14 RSI): 62.79 Buy
Chaikin Money Flow: -87692 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.76 - 1.9) Buy
Bollinger Bands (100): (1.72 - 1.92) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.94 Sell
Relative Strength Index (14 RSI): 33.84 Sell
Chaikin Money Flow: -502758 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.52 - 119.16) Sell
Bollinger Bands (100): (114.38 - 127.78) Sell

FSP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.89 Buy
20-day SMA: 1.84 Buy
50-day SMA: 1.86 Buy
200-day SMA: 1.77 Buy
8-day EMA: 1.91 Buy
20-day EMA: 1.87 Buy
50-day EMA: 1.85 Buy
200-day EMA: 1.85 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 111.57 Sell
20-day SMA: 114.25 Sell
50-day SMA: 119.8 Sell
200-day SMA: 128.55 Sell
8-day EMA: 110.88 Sell
20-day EMA: 113.91 Sell
50-day EMA: 117.81 Sell
200-day EMA: 123.39 Sell

Franklin Street Properties Earnings Growth & FSP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.70 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.63 per share, and an increase next year of $4.84 per share.

Franklin Street Properties Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):